This article has Open Peer Review reports available.
Portal hypertensive enteropathy diagnosed by capsule endoscopy and demonstration of the ileal changes after transjugular intrahepatic portosystemic shunt placement: a case report
© Pezzoli et al; licensee BioMed Central Ltd. 2011
Received: 5 March 2010
Accepted: 4 March 2011
Published: 4 March 2011
Recent data suggest that mucosal abnormalities can occur even in the duodenum, jejunum, and distal ileum of cirrhosis patients. We present a case of portal hypertensive enteropathy in a cirrhosis patient shown by capsule endoscopy and the effect of transjugular intrahepatic portosystemic shunt on the ileal pictures.
An 83-year-old Caucasian woman was admitted to our hospital for anemia and a positive fecal occult blood test. An upper gastrointestinal endoscopy revealed small varices without bleeding signs and hypertensive gastropathy. Colonoscopy was negative. To rule out any other cause of bleeding, capsule endoscopy was performed; capsule endoscopy revealed severe hyperemia of the jejunum-ileal mucosa with active bleeding. Because of the persistence of anemia and the frequent blood transfusions, not responding to β-blocker drugs or octreotide infusion, a transjugular intrahepatic portosystemic shunt was performed. Anemia improved quickly after the transjugular intrahepatic portosystemic shunt, and no further blood transfusion was necessary in the follow-up. The patient developed portal encephalopathy two months later and was readmitted to our department. We repeated the capsule endoscopy that showed a significant improvement of the gastric and ileal mucosa without any signs of bleeding.
Hypertensive enteropathy is a rare condition, but it seems more common with the introduction of capsule endoscopy in clinical practice. This case shows that the jejunum can be a source of bleeding in cirrhosis patients, and this is the first demonstration of its resolution after transjugular intrahepatic portosystemic shunt placement.
Changes in the gastric mucosa are a well-known aspect of cirrhosis in patients with portal hypertension . Some data suggest that similar abnormalities can also occur in the duodenum, jejunum, and distal ileum [2–4]. With the introduction of capsule endoscopy (CE) in clinical practice, these changes can be detected easily, and the so-called "portal hypertensive enteropathy"  seems more common [6–9]. We present a case of portal hypertensive enteropathy (PHE) in a cirrhosis patient shown by CE and the effect of transjugular intrahepatic portosystemic shunt (TIPS) placement on the ileal pictures.
In this case report, we describe the changes that occurred in the gastric and jejunal mucosa in a cirrhosis patient with portal hypertension with CE, and we report the positive effect of a TIPS placement. The clinical value and prevalence of PHE are not well known, but with the advent of CE, this entity seems more common, and some authors report a prevalence of more than 60% [6–9].
These data confirm that the hemodynamic alteration of portal hypertension can produce relevant effects in the small bowel mucosa, similar to those found in the gastric mucosa.
De Palma et al. and Goulas et al. observed that the frequency of the PHE increases with worsening of Child-Pugh class, but other authors have not found this correlation [8, 9]. Moreover, active ileal bleeding has been observed in 5% to 10% of cirrhosis patients [6, 9]. Our patient had anemia as the main symptom; she had severe portal hypertension, although no variceal bleeding was observed, and the global liver function was satisfactory. In our patient, the anemia was due both to portal hypertensive gastropathy and to active bleeding observed in the jejunum by CE. The correlation between portal hypertensive gastropathy and PHE was also observed in a previous study .
A multicenter study, published in abstract form, reported the results of CE in cirrhosis patients with unexplained bleeding , stressing the usefulness of CE results in the management of patients with portal hypertension. Our patient was treated with β-blockers and octreotide, without any significant effect. A number of pharmacologic agents have been used in acute bleeding due to portal hypertensive gastropathy; nonselective β-blockers and octreotide have been found to be successful in a high percentage of cases, whereas vasopressin and omeprazole were not so effective. Few data are available regarding the management of chronic bleeding, and the use of β-blockers has shown minimal improvement in such patients . The effect of drug therapy on PHE was reported in anecdotal cases only. Surgical shunt is another option in patients with severe portal hypertension, but we did not consider it for this patient because of the high operative risk and multiple co-morbidities. In our case, the CE finding has prompted us to consider TIPS placement to control bleeding. TIPS is a well-known technique to reduce portal hypertension and to control variceal bleeding , but no data are available about its effect on jejunal mucosa in cases of PHE. The American Association for the Study of Liver Disease (AASLD) suggests TIPS as the preferred approach for prevention of recurrent bleeding in patients with ectopic varices . Our patient showed an improvement of anemia after TIPS, and we were able to show the beneficial effect of TIPS placement on mucosal damage. Unfortunately, the patient died about three months later but we know that the one-year survival after TIPS varies from 48% to 90%, according to the severity of the liver disease . Nonetheless, this case shows that the decompression of the portal vein after TIPS placement had a positive effect, not only on esophageal varices and hypertensive gastropathy, but also on the duodenal-jejunal mucosa. To our knowledge, this is the first description of a significant improvement of PHE after TIPS placement documented by CE.
CE has made it possible to examine the small bowel mucosa directly and has allowed endoscopists to visualize the mucosal changes in cirrhosis patients with portal hypertension. This case underlines the fact that hemodynamic alterations of portal hypertension can produce relevant effects on the small-bowel mucosa. Therefore, we must bear in mind that the jejunum can also be a source of bleeding, and in cirrhosis patients with unexplained anemia, CE should be considered to optimize the treatment of portal hypertension.
Written informed consent was obtained from the next-of-kin for publication of this manuscript and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal
We thank Ms Alison Milne for reviewing the English version of the manuscript
- Baxter J, Dobbs B: Portal hypertensive gastropathy. J Gastroenterol Hepatol. 1988, 3: 635-644. 10.1111/j.1440-1746.1988.tb00794.x.View ArticleGoogle Scholar
- Nagral AS, Joshi AS, Bhatia SL, Abraham P, Mistry FP, Vora IM: Congestive jejunopathy in portal hypertension. Gut. 1993, 34: 694-697. 10.1136/gut.34.5.694.View ArticlePubMedPubMed CentralGoogle Scholar
- Viggiano TR, Gostout CJ: Portal hypertensive vasculopathy: a review of the clinical endoscopic and histophological features. Am J Gastroenterol. 1992, 87: 944-954.PubMedGoogle Scholar
- Misra SP, Dwivedi M, Misra V, Gupta M: Ileal varices and portal hypertensive ileopathy in patients with cirrhosis and portal hypertension. Gastrointest Endosc. 2004, 60: 778-783. 10.1016/S0016-5107(04)02049-8.View ArticlePubMedGoogle Scholar
- Rondonotti E, Villa F, Signorelli C, De Franchis R: Portal hypertensive enteropathy. Gastrointest Endosc Clin North Am. 2006, 16: 277-286. 10.1016/j.giec.2006.01.019.View ArticleGoogle Scholar
- De Palma G, Rega M, Masone S, Persico F, Siciliano S, Patrone F, Matantuono , Persico G: Mucosal abnormalities of the small bowel in patients with cirrhosis and portal hypertension: a capsule endoscopy study. Gastrointest Endosc. 2005, 62: 529-534. 10.1016/S0016-5107(05)01588-9.View ArticlePubMedGoogle Scholar
- Goulas S, Triantafyllidou K, Karagiannis S, Nicolaou P, Galanis P, Vafiadis I, Tzivras M, Mavrogiannis C: Capsule endoscopy in the investigation of patients with portal hypertension and anaemia. Can J Gastroenterol. 2008, 22: 469-474.View ArticlePubMedPubMed CentralGoogle Scholar
- Urbain D, Vandebosch S, Hindryckx P, Colle I, Reynaert H, Mana F, Vanden Branden S, Van Vlierberghe H, De Vos M, De Looze D: Capsule endoscopy findings in cirrhosis with portal hypertension: a prospective study. Dig Liver Dis. 2008, 40: 391-393. 10.1016/j.dld.2007.12.015.View ArticleGoogle Scholar
- Figuereido P, Almeida N, Lèrias C, Lopes S, Gouveia H, Leitao MC, Freitas D: Effect of portal hypertension in the small bowel: an endoscopic approach. Dig Dis Sci. 2008, 53: 2144-2150. 10.1007/s10620-007-0111-z.View ArticleGoogle Scholar
- North Italian Endoscopic Club for the Study and Treatment of Oesophageal Varices: Prediction of the first variceal haemorrhage in patients with cirrhosis of the liver and oesophageal varices: a prospective multicenter study. N Engl J Med. 1988, 319: 983-989. 10.1056/NEJM198810133191505.View ArticleGoogle Scholar
- Jacob P, Favre O, Daudet J, Lapalus M, Ben Soussan E, Saurin J: Clinical impact of capsule endoscopy for unexplained bleeding in cirrhosis, results from 21 patients. Endoscopy. 2005, 37 (suppl I): A287-Google Scholar
- Cubillas R, Rokey P: Portal hypertensive gastropathy: a review. Liver Int. 2010, 30: 1094-1102. 10.1111/j.1478-3231.2010.02286.x.View ArticlePubMedGoogle Scholar
- Luca A, D'Amico G, La Galla R, Mirini M, Morabito A, Pagliaro L: TIPS for prevention of recurrent bleeding in patients with cirrhosis: meta-analysis of randomized clinical trials. Radiology. 1999, 212: 411-421.View ArticlePubMedGoogle Scholar
- Boyer TD, Haskal ZJ: The role of transjugular intrahepatic portosystemic shunts in the management of portal hypertension. Hepatology. 2005, 41: 386-399. 10.1002/hep.20559.View ArticlePubMedGoogle Scholar
- Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, Borg PC: A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology. 2000, 31: 864-10.1053/he.2000.5852.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.